查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1974164

超音波市場：按產品、組件、便攜性、顯示類型、應用和最終用戶分類－全球預測，2026-2032年

Ultrasound Market by Product, Component, Portability, Display Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，超音波市場價值將達到 95.1 億美元，到 2026 年將成長到 100.1 億美元，到 2032 年將達到 139.4 億美元，複合年成長率為 5.61%。

主要市場統計數據
基準年 2025 95.1億美元
預計年份：2026年 100.1億美元
預測年份：2032年 139.4億美元
複合年成長率 (%) 5.61%

簡要概述不斷發展的超音波環境：技術融合、不斷變化的臨床需求以及在醫療保健服務中的戰略意義。

超音波系統正經歷著根本性的變革，其驅動力來自技術創新、臨床工作流程的轉變以及相關人員期望的不斷變化。影像物理學的進步、軟體驅動的影像增強技術以及人工智慧（AI）的發展，正在重新定義臨床醫生對超音波作為診斷和治療手段的期望。同時，對照護現場診斷日益成長的需求、對經濟高效診療路徑的重視以及服務向傳統醫院環境之外的轉移，正在重塑部署模式和採購重點。

人工智慧、小型化和不斷發展的經營模式正在改寫整個醫療保健領域超音波的應用和臨床整合規則。

超音波診斷領域正經歷快速發展和顛覆性的變革，多種轉型趨勢正在匯聚，改變影像和治療的實施方式。首先，人工智慧和先進訊號處理技術的融合正從試點研究逐步走向臨床工作流程的整合，實現了即時影像增強、自動測量和決策支援。這不僅降低了操作者差異，也使得非專業人員能夠廣泛應用超音波診斷技術。這一趨勢推動了對不僅精準，而且能夠與電子健康記錄（EHR）和遠端醫療平台無縫整合的系統的需求。

評估 2025 年美國關稅變化將如何重塑超音波相關人員。

2025年，美國新的關稅趨勢對超音波設備製造商和醫療服務提供者的供應鏈經濟和採購決策構成了重大限制。關鍵零件、子系統和成品關稅的增加導致成本上升，即時造成價格壓力，影響採購週期、資本支出核准和總擁有成本（TCO）的計算。對於擁有複雜全球供應鏈的產品以及依賴國內不易取得的專用零件的產品而言，這種壓力尤其嚴重。

詳細的細分分析揭示了產品、組件、便攜性、顯示、應用和最終用戶方面的差異如何影響部署和商業化策略。

市場區隔有助於明確產品開發、商業化策略和臨床應用。從產品層面來看，市場可分為診斷超音波系統和治療超音波設備。診斷超音波系統可細分為2D超音波、3D/四維超音波和多普勒超音波，而治療超音波設備則包括體外震波碎石術（ESWL）、高強度聚焦超音波（HIFU）和技術超音波。這種產品層面的區分凸顯了不同的技術重點。診斷系統強調影像保真度、工作流程整合和人體工學，而治療平台則優先考慮能量傳遞的精確性、標靶準確性和安全通訊協定。

美洲、歐洲、中東和非洲以及亞太地區的區域差異如何影響超音波技術的採用、監管和商業化策略？

區域趨勢在技術採納、監管管道和商業策略制定中發揮著至關重要的作用。在美洲，需求主要由以下因素驅動：追求高性能診斷能力的先進醫院系統、照護現場超音波的廣泛應用，以及人們對降低手術創傷性的治療方式日益成長的興趣。該地區也大力投資數位醫療整合，醫保報銷環境也越來越認可影像主導治療管道的價值。

競爭行為和企業策略揭示了研發深度、軟體生態系統和服務模式為何是領先超音波製造商之間決定性的差異化因素。

超音波領域的主要企業正同時關注多個策略要素：持續增加對探頭技術和影像處理的研發投入，拓展軟體和雲端服務，以及採用以服務合約和軟體訂閱為核心的商業模式，以實現持續的收入成長。與學術機構和臨床網路的合作也日益普遍，旨在獲取真實世界的臨床證據，以支持人工智慧演算法的獨立檢驗、多中心性能數據，並與監管核准和支付方合作。

產業領導者應採取的實際策略重點和實施步驟，以將技術進步和政策轉變轉化為永續的競爭優勢。

產業領導者必須果斷迅速採取行動，將結構性趨勢轉化為永續的優勢。首先，應優先投資於人工智慧和內建軟體，以切實提高診斷準確性和工作流程效率，並將演算法進步與嚴格的臨床檢驗和透明的性能指標相結合，從而確保臨床醫生的信心並獲得監管部門的核准。其次，應重組供應鏈以提高柔軟性：對二級供應商進行認證，擴大區域製造和組裝能力，並設計允許組件互換而無需進行重大重新設計的產品架構。

為了檢驗臨床技術和商業性結論，我們採用了嚴格的混合方法研究方法，結合了二手證據、一手專家訪談和三角驗證。

本分析的調查方法結合了定性和定量方法，以確保獲得平衡且基於證據的觀點。研究使用了二手資料，包括同行評審的臨床文獻、監管指導文件以及醫療設備製造商提供的公開資訊，以此建立關於技術能力、安全標準和近期核准情況的客觀基礎。此外，研究還對臨床醫生、生物醫學工程師、採購經理和行業高管進行了結構化的訪談，以收集關於推廣應用障礙、工作流程影響和採購行為的實際見解。

融合檢驗的人工智慧、敏捷的供應鏈和整合服務模式：策略洞察支撐著它們為何定義超音波診斷領域的未來領導地位。

總之，超音波正從一項成熟的影像技術轉型為集診斷、治療和數位健康於一體的動態平台。人工智慧、改進的探頭設計以及可攜式外形規格等技術進步正在拓展其臨床應用場景，並催生出結合軟體、服務和以結果為導向的合約的新型經營模式。 2025年的關稅調整和地緣政治發展正在加速關於供應鏈韌性、製造地和採購標準的討論，並著重於風險緩解和生命週期價值。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 工業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：超音波市場：依產品分類

  • 診斷超音波系統
    • 2D超音波
    • 3D和4D超音波
    • 多普勒超音波
  • 治療性超音波設備
    • 體外震波碎石術（ESWL）
    • 高強度聚焦超音波（HIFU）
    • 技術超音波

第9章：超音波市場：依組件分類

  • 探測
  • 工作站

第10章：超音波市場：可攜式

  • 推車底座
  • 可攜式和手持式

第11章：超音波市場：依顯示類型分類

  • 黑白超音波設備
  • 彩色超音波設備

第12章超音波市場：依應用領域分類

  • 介入性手術
    • 麻醉和疼痛管理
    • 切片檢查和引流
  • 醫學診斷
    • 腹部影像
    • 乳腺影像
    • 心臟病學
    • 胃腸病學
    • 肌肉骨骼影像
    • 婦產科
    • 腫瘤學
    • 眼科
    • 泌尿系統
  • 研究與開發
  • 獸醫學

第13章：超音波市場：依最終用戶分類

  • 門診部
  • 醫院
  • 婦產科中心
  • 研究所

第14章：超音波市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章：超音波市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章：超音波市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章：美國超音波市場

第18章：中國超音波市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • ALPINION Medical Systems Co., Ltd.
  • Analogic Corporation
  • B. Braun SE
  • Bioevopeak Co., Ltd.
  • Butterfly Network, Inc.
  • Canon Medical Systems Corporation
  • Cephasonics Ultrasound by White Eagle Sonic Technologies, Inc.
  • CIVCO Medical Solutions
  • CS Medical LLC
  • Echonous Inc.
  • Edan Instruments, Inc.
  • Esaote SpA
  • Fujifilm Holdings Corporation
  • GE HealthCare Technologies Inc.
  • Hitachi, Ltd.
  • Hologic Inc.
  • Konica Minolta Inc.
  • Koninklijke Philips NV
  • Samsung Medison Co., Ltd.
  • Shantou Institute of Ultrasonic Instruments Co., Ltd（SIUI）
  • Shimadzu Corporation
  • Siemens Healthcare Private Limited
  • SonoScape Medical Corp.
  • SternMed GmbH
  • Stryker Corporation
  • Telemed Medical Systems srl
  • WuHan Youkey Bio-Medical Electronics Co., Ltd.
Product Code: MRR-5D340F4413C5

The Ultrasound Market was valued at USD 9.51 billion in 2025 and is projected to grow to USD 10.01 billion in 2026, with a CAGR of 5.61%, reaching USD 13.94 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 9.51 billion
Estimated Year [2026] USD 10.01 billion
Forecast Year [2032] USD 13.94 billion
CAGR (%) 5.61%

A concise orientation to the evolving ultrasound landscape explaining technological convergence, clinical demand shifts, and strategic implications for care delivery

The ultrasound ecosystem is undergoing a fundamental transformation driven by converging technological innovations, shifting clinical workflows, and evolving stakeholder expectations. Advances in imaging physics, software-driven image enhancement, and artificial intelligence are redefining what clinicians expect from ultrasound as a diagnostic and therapeutic modality. At the same time, rising demand for point-of-care diagnostics, greater emphasis on cost-effective care pathways, and the migration of services outside traditional hospital settings are reshaping adoption patterns and procurement priorities.

This introduction synthesizes the forces that are driving new use cases and placing ultrasound at the center of non-invasive, real-time clinical decision-making. As clinicians push for earlier detection, shorter procedure times, and safer interventional guidance, the role of ultrasound is expanding beyond conventional imaging into therapeutic applications and integrated care platforms. The migration from fixed imaging suites to handheld and cart-based systems exemplifies how portability and immediate access are redefining clinical workflows across specialties.

Moreover, the interplay between hardware innovation and software ecosystems is creating a market where device performance, clinical validation, and software interoperability are equally important. Consequently, stakeholders must evaluate product roadmaps not only for transducer and console improvements but also for data management, cybersecurity, and AI-enabled clinical decision support. This framing sets the stage for deeper analysis of the structural shifts, policy impacts, segmentation dynamics, regional differences, and competitive behaviors explored in the subsequent sections.

How AI, miniaturization, and shifting commercial models are rewriting the rules of ultrasound adoption and clinical integration across care settings

The landscape of ultrasound is shifting in ways that are both evolutionary and disruptive, with several transformative trends converging to change how imaging and therapy are delivered. First, the integration of artificial intelligence and advanced signal processing has moved from pilot studies to embedded clinical workflows, enabling real-time image enhancement, automated measurements, and decision-support that reduce operator variability and unlock broader use by non-specialists. This drives demand for systems that are not only accurate but also seamlessly integrated with electronic health records and telehealth platforms.

Concurrently, miniaturization and improvements in probe design have accelerated the transition from large cart-based consoles to lightweight portable and handheld devices, expanding access in emergency care, outpatient clinics, and remote settings. These shifts are complemented by the growing clinical acceptance of therapeutic ultrasound modalities such as high-intensity focused ultrasound and shockwave therapies, which are increasingly viewed as non-invasive alternatives that can reduce hospital stays and improve patient throughput.

In addition, commercial models are transforming: subscription-based software, image-as-a-service platforms, and outcome-based procurement are altering purchasing decisions and long-term vendor relationships. Regulatory frameworks and reimbursement pathways are adapting to accommodate AI-enabled tools and software updates, which in turn alters time-to-market strategies and ongoing compliance obligations. Together, these trends are not only altering product development priorities but also creating new competitive battlegrounds where data, software ecosystems, and service capabilities matter as much as transducer performance.

Assessment of how U.S. tariff shifts in 2025 are reshaping procurement, supply chain resilience, and long-term manufacturing decisions for ultrasound stakeholders

In 2025, new tariff dynamics in the United States have introduced a material constraint on supply chain economics and procurement decision-making for ultrasound manufacturers and healthcare providers. Tariff-driven cost increases on critical components, subsystems, or finished devices create immediate pricing pressures that reverberate across procurement cycles, capital expenditure approvals, and total cost of ownership calculations. These pressures are most acute for products with complex global supply chains and dependence on specialized components that are not readily sourced domestically.

As a result, organizations are responding with a combination of tactical and strategic measures that mitigate exposure while preserving access to essential technologies. In the near term, manufacturers are accelerating efforts to redesign products for component flexibility, qualify secondary suppliers in tariff-neutral jurisdictions, and absorb short-term costs through pricing strategies designed to maintain market competitiveness. At the same time, procurement teams within provider organizations are recalibrating tender specifications to include supply chain resilience criteria, extended warranty terms, and service-level guarantees that hedge against component-related disruptions.

Over a medium-term horizon, tariffs are prompting broader reconsideration of manufacturing footprints and supplier relationships. Some companies are increasing local assembly or final-stage manufacturing to reduce border-related charges, while others pursue nearshoring of critical subassembly production. The cumulative effect of these changes influences product roadmaps-particularly for portable and handheld devices where trade-off decisions around probe complexity, digital processing, and embedded software have significant cost implications. Importantly, tariffs also accelerate strategic dialogues between manufacturers and payers about value-based procurement, total cost of ownership, and lifecycle support models, as both parties seek to preserve access to advanced imaging and therapeutic options without shifting unsustainable costs onto patients.

Detailed segmentation analysis revealing how product, component, portability, display, application, and end-user distinctions shape adoption and commercialization strategies

Segmentation drives clarity in product development, commercialization strategies, and clinical adoption. Based on Product, the market differentiates between Diagnostic Ultrasound Systems and Therapeutic Ultrasound Devices, where Diagnostic Ultrasound Systems are further divided into 2D Ultrasound, 3D & 4D Ultrasound, and Doppler Ultrasound, while Therapeutic Ultrasound Devices encompass Extracorporeal Shockwave Lithotripsy (ESWL), High-Intensity Focused Ultrasound (HIFU), and Technical Ultrasound. This product-level distinction highlights divergent engineering priorities: diagnostic systems emphasize image fidelity, workflow integration, and ergonomics, whereas therapeutic platforms prioritize energy delivery precision, targeting accuracy, and safety protocols.

Based on Component, the market is commonly considered across Probes and Workstations, making it clear that probe innovation-miniaturization, bandwidth, and multimodal capabilities-often drives perceived clinical value, while workstation software, processing power, and interoperability determine clinical efficiency and scalability. Based on Portability, the competitive landscape includes Cart Based and Portable & Handheld devices, with portability defining new access points for imaging services and creating distinct regulatory and reimbursement considerations.

Based on Display Type, distinctions between BW Ultrasound Devices and Color Ultrasound Devices continue to influence purchasing decisions in specialties where vascular flow visualization or detailed tissue characterization is critical. Based on Application, ultrasound use spans Interventional Procedures, Medical Diagnostics, Research & Development, and Veterinary sectors, with Interventional Procedures further broken into Anesthesia & Pain Management and Biopsies & Drainage, and Medical Diagnostics subdivided into Abdominal Imaging, Breast Imaging, Cardiology, Gastroenterology, Musculoskeletal Imaging, Obstetrics & Gynecology, Oncology, Ophthalmology, and Urology. Finally, based on End User, adoption and service models vary across Ambulatory Centers, Hospitals, Maternity Centers, and Research Laboratories, each with distinct procurement cycles, staffing profiles, and capital planning constraints.

This layered segmentation underscores why competitive strategies must be multi-dimensional: a single device can occupy multiple segments, and success requires aligning product specifications, distribution channels, and training programs to the nuanced needs of each clinical and commercial segment.

How regional differences across the Americas, Europe Middle East & Africa, and Asia-Pacific drive distinct adoption, regulatory, and commercialization strategies for ultrasound technologies

Regional dynamics are instrumental in shaping technology adoption, regulatory pathways, and commercial strategies. In the Americas, demand is driven by advanced hospital systems seeking high-performance diagnostic capabilities, growing adoption of point-of-care ultrasound, and heightened interest in therapeutic modalities that reduce procedural invasiveness. This region also exhibits proactive investment in digital health integration and reimbursement environments that increasingly recognize the value of imaging-driven care pathways.

In Europe, Middle East & Africa, heterogeneity defines market behavior: Western European markets typically prioritize clinical validation, interoperability, and long-term service partnerships, while emerging markets in the Middle East and Africa present opportunities for lower-cost portable solutions and public-private partnerships that expand access to imaging. Regulatory frameworks across the region vary substantially, necessitating tailored market entry strategies that reflect country-level approval requirements and procurement norms.

In Asia-Pacific, rapid infrastructure expansion, large patient volumes, and strong domestic manufacturing capabilities create both intense competition and significant opportunity. Several countries in this region are advancing local production, investing in AI research collaborations, and prioritizing telemedicine-enabled diagnostics to reach underserved populations. Across regions, differences in reimbursement, clinical practice patterns, and capital allocation cycles require companies to tailor product portfolios, pricing, and service models to regional realities while maintaining global consistency in quality and compliance.

Competitive behaviors and corporate strategies revealing why R&D depth, software ecosystems, and service models are the defining differentiators among leading ultrasound manufacturers

Leading companies in the ultrasound space are concentrating on several strategic levers simultaneously: sustained R&D investment in probe technology and image processing, expansion of software and cloud services, and commercial models that emphasize recurring revenue through service contracts and software subscriptions. Partnerships with academic centers and clinical networks are increasingly common as companies seek independent validation of AI algorithms, multi-center performance data, and real-world evidence to support regulatory approvals and payer engagement.

Competitive behavior is also characterized by targeted M&A and strategic alliances that fill capability gaps-acquiring niche AI startups, bolstering service networks, or integrating telehealth platforms to complement imaging offerings. In parallel, firms are diversifying manufacturing footprints and qualifying alternative suppliers to reduce exposure to geopolitical and tariff-related risks. Talent acquisition strategies prioritize clinicians, data scientists, and regulatory specialists who can accelerate translation of algorithmic capabilities into clinically validated workflows.

Service and training are emerging as differentiators: vendors that provide comprehensive education programs, remote proctoring, and robust post-sale support strengthen clinical adoption and reduce churn. Additionally, companies that commit to transparent clinical evidence and open software ecosystems create higher barriers to entry for new competitors and build trust with procurement committees focused on interoperability and lifecycle value. These collective behaviors suggest a market where innovation, strategic partnerships, and service excellence determine leadership.

Practical strategic priorities and executional steps that industry leaders should adopt to convert technological advances and policy shifts into sustainable competitive advantage

Industry leaders must act with clarity and speed to convert structural trends into sustainable advantage. First, prioritize investment in artificial intelligence and embedded software that demonstrably improves diagnostic accuracy and workflow efficiency, pairing algorithmic advances with rigorous clinical validation and transparent performance metrics to secure clinician trust and regulatory acceptance. Second, reengineer supply chains for flexibility: qualify secondary suppliers, expand regional manufacturing or assembly capabilities, and design product architectures that allow component substitution without heavy redesign.

Third, develop differentiated commercial models that combine hardware sales with subscription-based software, training packages, and outcome-linked service agreements. This will create recurring revenue and deepen customer relationships while aligning incentives around clinical outcomes. Fourth, accelerate the development of portable and handheld platforms targeted to point-of-care settings, ensuring these devices include seamless connectivity, telemedicine integration, and simplified user interfaces to broaden adoption beyond specialty imaging departments.

Fifth, invest in global regulatory expertise and payer engagement strategies to optimize reimbursement prospects for AI-enabled tools and therapeutic ultrasound applications. Sixth, build service and training programs that reduce time to proficiency and demonstrate return on investment for health systems. Finally, pursue strategic partnerships with clinical centers and technology providers to co-develop validated workflows, which will shorten adoption cycles and create defensible clinical differentiation. Acting on these priorities will position organizations to capture both short-term opportunities and long-term leadership in a rapidly evolving landscape.

A rigorous mixed-methods research approach combining secondary evidence, primary expert interviews, and triangulation to validate clinical, technical, and commercial conclusions

The research methodology underpinning this analysis combined qualitative and quantitative approaches to ensure a balanced, evidence-based perspective. Secondary sources included peer-reviewed clinical literature, regulatory guidance documents, and public disclosures from device manufacturers to establish a factual baseline on technology capabilities, safety standards, and recent approvals. These were complemented by structured primary interviews with clinicians, biomedical engineers, procurement leaders, and industry executives to capture practical insights into adoption barriers, workflow impact, and procurement behavior.

Data triangulation was applied to reconcile differing viewpoints and ensure robust conclusions: clinical feedback was compared against regulatory trends and manufacturer roadmaps, while supply chain observations were validated through supplier and distributor interviews. Segmentation mapping involved cross-referencing product capabilities with clinical needs and end-user profiles to identify where innovations would have the greatest practical impact. Where possible, technical specifications and clinical validation studies were reviewed to corroborate claims about performance improvements.

Limitations of the methodology include reliance on available public data for certain proprietary technologies and potential variability in clinician perspectives across geographies and specialties. To mitigate these limitations, the research incorporated multiple stakeholder perspectives and prioritized evidence from clinical trials and peer-reviewed evaluations when assessing the efficacy and safety of emerging modalities.

Synthesis of strategic implications confirming why validated AI, supply chain agility, and integrated service models define future leadership in ultrasound

In conclusion, ultrasound is transitioning from a mature imaging modality to a dynamic platform at the intersection of diagnostics, therapy, and digital health. Technological advances such as AI, improved probe design, and portable form factors are expanding clinical use cases and creating new business models that bundle software, services, and outcome-oriented agreements. Tariff changes and geopolitical dynamics in 2025 have accelerated conversations about supply chain resilience, manufacturing footprints, and procurement criteria centered on risk mitigation and lifecycle value.

Segmentation nuances-spanning diagnostic versus therapeutic applications, component-level priorities, portability distinctions, display requirements, application-specific workflows, and end-user profiles-continue to drive strategic differentiation and product design choices. Regional variation in regulatory regimes, reimbursement, and clinical practice patterns further underscores the need for tailored go-to-market approaches. Competitive success will favor organizations that can pair technical excellence with credible clinical evidence, robust service models, and flexible commercial terms.

Ultimately, stakeholders that proactively invest in validated AI capabilities, supply chain agility, and integrated service offerings will be best positioned to capture the expanding role of ultrasound in modern care delivery. The insights in this report are intended to inform strategic planning, guide product development priorities, and support commercial decisions that accelerate adoption while safeguarding clinical quality and operational resilience.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Ultrasound Market, by Product

  • 8.1. Diagnostic Ultrasound Systems
    • 8.1.1. 2D Ultrasound
    • 8.1.2. 3D & 4D Ultrasound
    • 8.1.3. Doppler Ultrasound
  • 8.2. Therapeutic Ultrasound Devices
    • 8.2.1. Extracorporeal Shockwave Lithotripsy (ESWL)
    • 8.2.2. High-Intensity Focused Ultrasound (HIFU)
    • 8.2.3. Technical Ultrasound

9. Ultrasound Market, by Component

  • 9.1. Probes
  • 9.2. Workstations

10. Ultrasound Market, by Portability

  • 10.1. Cart Based
  • 10.2. Portable & Handheld

11. Ultrasound Market, by Display Type

  • 11.1. BW Ultrasound Devices
  • 11.2. Color Ultrasound Devices

12. Ultrasound Market, by Application

  • 12.1. Interventional Procedures
    • 12.1.1. Anesthesia & Pain Management
    • 12.1.2. Biopsies & Drainage
  • 12.2. Medical Diagnostics
    • 12.2.1. Abdominal Imaging
    • 12.2.2. Breast Imaging
    • 12.2.3. Cardiology
    • 12.2.4. Gastroenterology
    • 12.2.5. Musculoskeletal Imaging
    • 12.2.6. Obstetrics & Gynecology
    • 12.2.7. Oncology
    • 12.2.8. Ophthalmology
    • 12.2.9. Urology
  • 12.3. Research & Development
  • 12.4. Veterinary

13. Ultrasound Market, by End User

  • 13.1. Ambulatory Centers
  • 13.2. Hospitals
  • 13.3. Maternity Centers
  • 13.4. Research Laboratories

14. Ultrasound Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Ultrasound Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Ultrasound Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Ultrasound Market

18. China Ultrasound Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. ALPINION Medical Systems Co., Ltd.
  • 19.6. Analogic Corporation
  • 19.7. B. Braun SE
  • 19.8. Bioevopeak Co., Ltd.
  • 19.9. Butterfly Network, Inc.
  • 19.10. Canon Medical Systems Corporation
  • 19.11. Cephasonics Ultrasound by White Eagle Sonic Technologies, Inc.
  • 19.12. CIVCO Medical Solutions
  • 19.13. CS Medical LLC
  • 19.14. Echonous Inc.
  • 19.15. Edan Instruments, Inc.
  • 19.16. Esaote SpA
  • 19.17. Fujifilm Holdings Corporation
  • 19.18. GE HealthCare Technologies Inc.
  • 19.19. Hitachi, Ltd.
  • 19.20. Hologic Inc.
  • 19.21. Konica Minolta Inc.
  • 19.22. Koninklijke Philips N.V
  • 19.23. Samsung Medison Co., Ltd.
  • 19.24. Shantou Institute of Ultrasonic Instruments Co., Ltd (SIUI)
  • 19.25. Shimadzu Corporation
  • 19.26. Siemens Healthcare Private Limited
  • 19.27. SonoScape Medical Corp.
  • 19.28. SternMed GmbH
  • 19.29. Stryker Corporation
  • 19.30. Telemed Medical Systems s.r.l
  • 19.31. WuHan Youkey Bio-Medical Electronics Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ULTRASOUND MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ULTRASOUND MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ULTRASOUND MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ULTRASOUND MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ULTRASOUND MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ULTRASOUND MARKET SIZE, BY PORTABILITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ULTRASOUND MARKET SIZE, BY DISPLAY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ULTRASOUND MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ULTRASOUND MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ULTRASOUND MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ULTRASOUND MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ULTRASOUND MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES ULTRASOUND MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA ULTRASOUND MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ULTRASOUND MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ULTRASOUND MARKET SIZE, BY DIAGNOSTIC ULTRASOUND SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ULTRASOUND MARKET SIZE, BY DIAGNOSTIC ULTRASOUND SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ULTRASOUND MARKET SIZE, BY DIAGNOSTIC ULTRASOUND SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ULTRASOUND MARKET SIZE, BY DIAGNOSTIC ULTRASOUND SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ULTRASOUND MARKET SIZE, BY 2D ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ULTRASOUND MARKET SIZE, BY 2D ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ULTRASOUND MARKET SIZE, BY 2D ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ULTRASOUND MARKET SIZE, BY 3D & 4D ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ULTRASOUND MARKET SIZE, BY 3D & 4D ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ULTRASOUND MARKET SIZE, BY 3D & 4D ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ULTRASOUND MARKET SIZE, BY DOPPLER ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ULTRASOUND MARKET SIZE, BY DOPPLER ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ULTRASOUND MARKET SIZE, BY DOPPLER ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ULTRASOUND MARKET SIZE, BY THERAPEUTIC ULTRASOUND DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ULTRASOUND MARKET SIZE, BY THERAPEUTIC ULTRASOUND DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ULTRASOUND MARKET SIZE, BY THERAPEUTIC ULTRASOUND DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ULTRASOUND MARKET SIZE, BY THERAPEUTIC ULTRASOUND DEVICES, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ULTRASOUND MARKET SIZE, BY EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY (ESWL), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ULTRASOUND MARKET SIZE, BY EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY (ESWL), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ULTRASOUND MARKET SIZE, BY EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY (ESWL), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ULTRASOUND MARKET SIZE, BY HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ULTRASOUND MARKET SIZE, BY HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ULTRASOUND MARKET SIZE, BY HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ULTRASOUND MARKET SIZE, BY TECHNICAL ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ULTRASOUND MARKET SIZE, BY TECHNICAL ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ULTRASOUND MARKET SIZE, BY TECHNICAL ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ULTRASOUND MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ULTRASOUND MARKET SIZE, BY PROBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ULTRASOUND MARKET SIZE, BY PROBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ULTRASOUND MARKET SIZE, BY PROBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ULTRASOUND MARKET SIZE, BY WORKSTATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ULTRASOUND MARKET SIZE, BY WORKSTATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ULTRASOUND MARKET SIZE, BY WORKSTATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ULTRASOUND MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ULTRASOUND MARKET SIZE, BY CART BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ULTRASOUND MARKET SIZE, BY CART BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ULTRASOUND MARKET SIZE, BY CART BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ULTRASOUND MARKET SIZE, BY PORTABLE & HANDHELD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ULTRASOUND MARKET SIZE, BY PORTABLE & HANDHELD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ULTRASOUND MARKET SIZE, BY PORTABLE & HANDHELD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ULTRASOUND MARKET SIZE, BY DISPLAY TYPE, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ULTRASOUND MARKET SIZE, BY BW ULTRASOUND DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ULTRASOUND MARKET SIZE, BY BW ULTRASOUND DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ULTRASOUND MARKET SIZE, BY BW ULTRASOUND DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ULTRASOUND MARKET SIZE, BY COLOR ULTRASOUND DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ULTRASOUND MARKET SIZE, BY COLOR ULTRASOUND DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ULTRASOUND MARKET SIZE, BY COLOR ULTRASOUND DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ULTRASOUND MARKET SIZE, BY INTERVENTIONAL PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ULTRASOUND MARKET SIZE, BY INTERVENTIONAL PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ULTRASOUND MARKET SIZE, BY INTERVENTIONAL PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ULTRASOUND MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ULTRASOUND MARKET SIZE, BY ANESTHESIA & PAIN MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ULTRASOUND MARKET SIZE, BY ANESTHESIA & PAIN MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ULTRASOUND MARKET SIZE, BY ANESTHESIA & PAIN MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ULTRASOUND MARKET SIZE, BY BIOPSIES & DRAINAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ULTRASOUND MARKET SIZE, BY BIOPSIES & DRAINAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ULTRASOUND MARKET SIZE, BY BIOPSIES & DRAINAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ULTRASOUND MARKET SIZE, BY MEDICAL DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ULTRASOUND MARKET SIZE, BY MEDICAL DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ULTRASOUND MARKET SIZE, BY MEDICAL DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ULTRASOUND MARKET SIZE, BY MEDICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ULTRASOUND MARKET SIZE, BY ABDOMINAL IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ULTRASOUND MARKET SIZE, BY ABDOMINAL IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ULTRASOUND MARKET SIZE, BY ABDOMINAL IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ULTRASOUND MARKET SIZE, BY BREAST IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ULTRASOUND MARKET SIZE, BY BREAST IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ULTRASOUND MARKET SIZE, BY BREAST IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ULTRASOUND MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ULTRASOUND MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ULTRASOUND MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ULTRASOUND MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ULTRASOUND MARKET SIZE, BY GASTROENTEROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ULTRASOUND MARKET SIZE, BY GASTROENTEROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ULTRASOUND MARKET SIZE, BY MUSCULOSKELETAL IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ULTRASOUND MARKET SIZE, BY MUSCULOSKELETAL IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL ULTRASOUND MARKET SIZE, BY MUSCULOSKELETAL IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL ULTRASOUND MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ULTRASOUND MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL ULTRASOUND MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL ULTRASOUND MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL ULTRASOUND MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL ULTRASOUND MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL ULTRASOUND MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL ULTRASOUND MARKET SIZE, BY OPHTHALMOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL ULTRASOUND MARKET SIZE, BY OPHTHALMOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL ULTRASOUND MARKET SIZE, BY UROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL ULTRASOUND MARKET SIZE, BY UROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL ULTRASOUND MARKET SIZE, BY UROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL ULTRASOUND MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL ULTRASOUND MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL ULTRASOUND MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL ULTRASOUND MARKET SIZE, BY VETERINARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL ULTRASOUND MARKET SIZE, BY VETERINARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL ULTRASOUND MARKET SIZE, BY VETERINARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL ULTRASOUND MARKET SIZE, BY AMBULATORY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL ULTRASOUND MARKET SIZE, BY AMBULATORY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL ULTRASOUND MARKET SIZE, BY AMBULATORY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL ULTRASOUND MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL ULTRASOUND MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL ULTRASOUND MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL ULTRASOUND MARKET SIZE, BY MATERNITY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL ULTRASOUND MARKET SIZE, BY MATERNITY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL ULTRASOUND MARKET SIZE, BY MATERNITY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL ULTRASOUND MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL ULTRASOUND MARKET SIZE, BY RESEARCH LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL ULTRASOUND MARKET SIZE, BY RESEARCH LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL ULTRASOUND MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS ULTRASOUND MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS ULTRASOUND MARKET SIZE, BY DIAGNOSTIC ULTRASOUND SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 115. AMERICAS ULTRASOUND MARKET SIZE, BY THERAPEUTIC ULTRASOUND DEVICES, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS ULTRASOUND MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS ULTRASOUND MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS ULTRASOUND MARKET SIZE, BY DISPLAY TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS ULTRASOUND MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS ULTRASOUND MARKET SIZE, BY MEDICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA ULTRASOUND MARKET SIZE, BY DIAGNOSTIC ULTRASOUND SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA ULTRASOUND MARKET SIZE, BY THERAPEUTIC ULTRASOUND DEVICES, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA ULTRASOUND MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA ULTRASOUND MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA ULTRASOUND MARKET SIZE, BY DISPLAY TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA ULTRASOUND MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA ULTRASOUND MARKET SIZE, BY MEDICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA ULTRASOUND MARKET SIZE, BY DIAGNOSTIC ULTRASOUND SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA ULTRASOUND MARKET SIZE, BY THERAPEUTIC ULTRASOUND DEVICES, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA ULTRASOUND MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA ULTRASOUND MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA ULTRASOUND MARKET SIZE, BY DISPLAY TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA ULTRASOUND MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA ULTRASOUND MARKET SIZE, BY MEDICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND MARKET SIZE, BY DIAGNOSTIC ULTRASOUND SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND MARKET SIZE, BY THERAPEUTIC ULTRASOUND DEVICES, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND MARKET SIZE, BY DISPLAY TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND MARKET SIZE, BY MEDICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE ULTRASOUND MARKET SIZE, BY DIAGNOSTIC ULTRASOUND SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE ULTRASOUND MARKET SIZE, BY THERAPEUTIC ULTRASOUND DEVICES, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE ULTRASOUND MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE ULTRASOUND MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE ULTRASOUND MARKET SIZE, BY DISPLAY TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE ULTRASOUND MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE ULTRASOUND MARKET SIZE, BY MEDICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST ULTRASOUND MARKET SIZE, BY DIAGNOSTIC ULTRASOUND SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST ULTRASOUND MARKET SIZE, BY THERAPEUTIC ULTRASOUND DEVICES, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST ULTRASOUND MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST ULTRASOUND MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST ULTRASOUND MARKET SIZE, BY DISPLAY TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST ULTRASOUND MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST ULTRASOUND MARKET SIZE, BY MEDICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA ULTRASOUND MARKET SIZE, BY DIAGNOSTIC ULTRASOUND SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA ULTRASOUND MARKET SIZE, BY THERAPEUTIC ULTRASOUND DEVICES, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA ULTRASOUND MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA ULTRASOUND MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA ULTRASOUND MARKET SIZE, BY DISPLAY TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 186. AFRICA ULTRASOUND MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 187. AFRICA ULTRASOUND MARKET SIZE, BY MEDICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 188. AFRICA ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC ULTRASOUND MARKET SIZE, BY DIAGNOSTIC ULTRASOUND SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC ULTRASOUND MARKET SIZE, BY THERAPEUTIC ULTRASOUND DEVICES, 2018-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC ULTRASOUND MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC ULTRASOUND MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC ULTRASOUND MARKET SIZE, BY DISPLAY TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC ULTRASOUND MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC ULTRASOUND MARKET SIZE, BY MEDICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. GLOBAL ULTRASOUND MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 203. ASEAN ULTRASOUND MARKET SIZE, BY DIAGNOSTIC ULTRASOUND SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 204. ASEAN ULTRASOUND MARKET SIZE, BY THERAPEUTIC ULTRASOUND DEVICES, 2018-2032 (USD MILLION)
  • TABLE 205. ASEAN ULTRASOUND MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 206. ASEAN ULTRASOUND MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 207. ASEAN ULTRASOUND MARKET SIZE, BY DISPLAY TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. ASEAN ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 209. ASEAN ULTRASOUND MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 210. ASEAN ULTRASOUND MARKET SIZE, BY MEDICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 211. ASEAN ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 212. GCC ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 213. GCC ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 214. GCC ULTRASOUND MARKET SIZE, BY DIAGNOSTIC ULTRASOUND SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 215. GCC ULTRASOUND MARKET SIZE, BY THERAPEUTIC ULTRASOUND DEVICES, 2018-2032 (USD MILLION)
  • TABLE 216. GCC ULTRASOUND MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 217. GCC ULTRASOUND MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 218. GCC ULTRASOUND MARKET SIZE, BY DISPLAY TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. GCC ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 220. GCC ULTRASOUND MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 221. GCC ULTRASOUND MARKET SIZE, BY MEDICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 222. GCC ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION ULTRASOUND MARKET SIZE, BY DIAGNOSTIC ULTRASOUND SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPEAN UNION ULTRASOUND MARKET SIZE, BY THERAPEUTIC ULTRASOUND DEVICES, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION ULTRASOUND MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPEAN UNION ULTRASOUND MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPEAN UNION ULTRASOUND MARKET SIZE, BY DISPLAY TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPEAN UNION ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPEAN UNION ULTRASOUND MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPEAN UNION ULTRASOUND MARKET SIZE, BY MEDICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPEAN UNION ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 236. BRICS ULTRASOUND MARKET SIZE, BY DIAGNOSTIC ULTRASOUND SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 237. BRICS ULTRASOUND MARKET SIZE, BY THERAPEUTIC ULTRASOUND DEVICES, 2018-2032 (USD MILLION)
  • TABLE 238. BRICS ULTRASOUND MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 239. BRICS ULTRASOUND MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 240. BRICS ULTRASOUND MARKET SIZE, BY DISPLAY TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. BRICS ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 242. BRICS ULTRASOUND MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 243. BRICS ULTRASOUND MARKET SIZE, BY MEDICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 244. BRICS ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 245. G7 ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 246. G7 ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 247. G7 ULTRASOUND MARKET SIZE, BY DIAGNOSTIC ULTRASOUND SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 248. G7 ULTRASOUND MARKET SIZE, BY THERAPEUTIC ULTRASOUND DEVICES, 2018-2032 (USD MILLION)
  • TABLE 249. G7 ULTRASOUND MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 250. G7 ULTRASOUND MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 251. G7 ULTRASOUND MARKET SIZE, BY DISPLAY TYPE, 2018-2032 (USD MILLION)
  • TABLE 252. G7 ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 253. G7 ULTRASOUND MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 254. G7 ULTRASOUND MARKET SIZE, BY MEDICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 255. G7 ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 256. NATO ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 257. NATO ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 258. NATO ULTRASOUND MARKET SIZE, BY DIAGNOSTIC ULTRASOUND SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 259. NATO ULTRASOUND MARKET SIZE, BY THERAPEUTIC ULTRASOUND DEVICES, 2018-2032 (USD MILLION)
  • TABLE 260. NATO ULTRASOUND MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 261. NATO ULTRASOUND MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 262. NATO ULTRASOUND MARKET SIZE, BY DISPLAY TYPE, 2018-2032 (USD MILLION)
  • TABLE 263. NATO ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 264. NATO ULTRASOUND MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 265. NATO ULTRASOUND MARKET SIZE, BY MEDICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 266. NATO ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 267. GLOBAL ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED STATES ULTRASOUND MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 269. UNITED STATES ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 270. UNITED STATES ULTRASOUND MARKET SIZE, BY DIAGNOSTIC ULTRASOUND SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 271. UNITED STATES ULTRASOUND MARKET SIZE, BY THERAPEUTIC ULTRASOUND DEVICES, 2018-2032 (USD MILLION)
  • TABLE 272. UNITED STATES ULTRASOUND MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 273. UNITED STATES ULTRASOUND MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 274. UNITED STATES ULTRASOUND MARKET SIZE, BY DISPLAY TYPE, 2018-2032 (USD MILLION)
  • TABLE 275. UNITED STATES ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 276. UNITED STATES ULTRASOUND MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 277. UNITED STATES ULTRASOUND MARKET SIZE, BY MEDICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 278. UNITED STATES ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 279. CHINA ULTRASOUND MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 280. CHINA ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 281. CHINA ULTRASOUND MARKET SIZE, BY DIAGNOSTIC ULTRASOUND SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 282. CHINA ULTRASOUND MARKET SIZE, BY THERAPEUTIC ULTRASOUND DEVICES, 2018-2032 (USD MILLION)
  • TABLE 283. CHINA ULTRASOUND MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 284. CHINA ULTRASOUND MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 285. CHINA ULTRASOUND MARKET SIZE, BY DISPLAY TYPE, 2018-2032 (USD MILLION)
  • TABLE 286. CHINA ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 287. CHINA ULTRASOUND MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 288. CHINA ULTRASOUND MARKET SIZE, BY MEDICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 289. CHINA ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)